[Bilateral acute depigmentation of the iris syndrome]

J Fr Ophtalmol. 2011 May;34(5):309-12. doi: 10.1016/j.jfo.2010.12.007. Epub 2011 May 4.
[Article in French]

Abstract

Bilateral acute depigmentation of the iris syndrome (BADI syndrome) is a new clinical entity. Young females from 20 to 45 years of age are most commonly affected. It is characterized by bilateral nontransilluminating depigmentation of the iris stroma. During the acute phase, this clinical entity also combines with red painful eye, pigmentation of the trabecular meshwork, anterior chamber flare, circulating pigment, and pigmented deposit on the endothelium cornea. At the acute stage, the symptoms are controlled with topical corticosteroid treatment. The prognosis is good. We report a 41-year-old woman presenting with BADI syndrome.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Acute Disease
  • Adult
  • Dexamethasone / therapeutic use
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Eye Color*
  • Eye Pain / etiology
  • Female
  • Humans
  • Iris Diseases / diagnosis
  • Iris Diseases / drug therapy
  • Iris Diseases / pathology*
  • Pigmentation Disorders / diagnosis
  • Pigmentation Disorders / drug therapy
  • Pigmentation Disorders / pathology*
  • Syndrome
  • Tobramycin / therapeutic use
  • Uveitis / diagnosis

Substances

  • Dexamethasone
  • Tobramycin